Showing results (451-460 of 630) with videos related to

Sort By:
Pageof 63
Dermatitis : Contact, Atopic, Occupational, Drug|December 4, 2020
Measurement Properties of Patient Health Questionnaire 9 and Patient Health Questionnaire 2 in Adult Patients With Atopic DermatitisJonathan I Silverberg, Brad Lee, Donald Lei, et al.
American Journal of Clinical Dermatology|May 22, 2023
Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE TrialEric L Simpson, Jonathan I Silverberg, Jacob P Thyssen, et al.
Journal of Patient-Reported Outcomes|July 18, 2019
Exploring content and psychometric validity of newly developed assessment tools for itch and skin pain in atopic dermatitisLouise Newton, Amy M DeLozier, Philip C Griffiths, et al.
The New England Journal of Medicine|March 15, 2023
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic DermatitisJonathan I Silverberg, Emma Guttman-Yassky, Diamant Thaçi, et al.
Dermatology and Therapy|August 9, 2024
Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab TreatmentJonathan I Silverberg, Andreas Wollenberg, Linda Stein Gold, et al.
Journal of Drugs in Dermatology : JDD|October 7, 2020
Impact of Atopic Dermatitis Lesion Location on Quality of Life in Adult Patients in a Real-world StudyPeter A Lio, Andreas Wollenberg, Jacob P Thyssen, et al.
Journal of the American Academy of Dermatology|November 30, 2020
Bidirectional association between atopic dermatitis, conjunctivitis, and other ocular surface diseases: A systematic review and meta-analysisNina H Ravn, Zohra F Ahmadzay, Tine A Christensen, et al.
American Journal of Clinical Dermatology|February 8, 2026
Expert Recommendations for the Diagnosis and Management of Chronic Hand Eczema in the United StatesJonathan I Silverberg, David Cohen, Emma Guttman-Yassky, et al.
JAMA Dermatology|March 2, 2017
Global Skin Disease Morbidity and Mortality: An Update From the Global Burden of Disease Study 2013Chante Karimkhani, Robert P Dellavalle, Luc E Coffeng, et al.
The Journal of Dermatological Treatment|November 23, 2020
Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trialsK Reich, A M DeLozier, F P Nunes, et al.
Pageof 63